Wellington Management Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-130,332
| Closed | -$1.08M | – | 1937 |
|
|
2019
Q4 | $1.08M | Sell |
130,332
-4,069,019
| -97% | -$33.8M | ﹤0.01% | 1687 |
|
|
2019
Q3 | $31M | Buy |
4,199,351
+878,794
| +26% | +$6.49M | 0.01% | 852 |
|
|
2019
Q2 | $37.3M | Buy |
3,320,557
+22,782
| +0.7% | +$256K | 0.01% | 843 |
|
|
2019
Q1 | $35.5M | Buy |
3,297,775
+620,117
| +23% | +$6.67M | 0.01% | 854 |
|
|
2018
Q4 | $40.4M | Buy |
2,677,658
+2,150,556
| +408% | +$32.5M | 0.01% | 777 |
|
|
2018
Q3 | $9.75M | Buy |
527,102
+132,110
| +33% | +$2.44M | ﹤0.01% | 1287 |
|
|
2018
Q2 | $9.03M | Sell |
394,992
-24,360
| -6% | -$557K | ﹤0.01% | 1316 |
|
|
2018
Q1 | $11.9M | Buy |
419,352
+367,302
| +706% | +$10.4M | ﹤0.01% | 1229 |
|
|
2017
Q4 | $1.1M | Buy |
52,050
+5,674
| +12% | +$120K | ﹤0.01% | 1856 |
|
|
2017
Q3 | $842K | Buy |
46,376
+30,331
| +189% | +$551K | ﹤0.01% | 1902 |
|
|
2017
Q2 | $249K | Buy |
+16,045
| New | +$249K | ﹤0.01% | 2111 |
|
|
2016
Q2 | – | Sell |
-749,055
| Closed | -$9.66M | – | 2081 |
|
|
2016
Q1 | $9.66M | Hold |
749,055
| – | – | ﹤0.01% | 1150 |
|
|
2015
Q4 | $15.6M | Buy |
+749,055
| New | +$15.6M | ﹤0.01% | 1035 |
|